NCT00717470View on ClinicalTrials.gov

A Study in Kidney Transplant Subjects to Investigate the Optimal Suppression of Immunity to Help Prevent Kidney Rejection

PHASE4CompletedINTERVENTIONAL
Enrollment

1,252

Participants

Timeline

Start Date

May 14, 2008

Primary Completion Date

March 2, 2010

Study Completion Date

March 2, 2010

Conditions
Kidney Transplantation
Interventions
DRUG

Prograf®

oral

DRUG

Advagraf®

oral

DRUG

Mycophenolate Mofetil

oral

DRUG

Simulect

oral

DRUG

methylprednisolone / prednisone

oral

Trial Locations (110)

1070

Brussels

1082

Budapest

1200

Brussels

2193

Johannesburg

3000

Leuven

6720

Szeged

7925

Cape Town

8091

Zurich

9000

Ghent

11009

Cadiz

11527

Athens

13353

Berlin

14021

Prague

15006

A Coruña

18012

Granada

18057

Rostock

20162

Milan

20251

Hamburg

24105

Kiel

28007

Madrid

28034

Madrid

28046

Madrid

29609

Brest

30120

Murcia

30625

Hanover

31054

Toulouse

31080

Pamplona

31100

Treviso

33006

Oviedo

33076

Bordeaux

35033

Rennes

35128

Padua

37007

Salamanca

37044

Tours

38700

La Tronche

40138

Bologna

41013

Seville

42055

Saint-Etienne

44035

Nantes

45147

Essen

46009

Valencia

46017

Valencia

48149

Münster

48903

Barakaldo-Vizcaya

49033

Angers

50005

Hradec Kravlove

50009

Zaragoza

52074

Aachen

53100

Siena

54511

Vandœuvre-lès-Nancy

54642

Thessaloniki

60020

Ancona

60590

Frankfurt

65691

Brno

67091

Strasbourg

67655

Kaiserslautern

69437

Lyon

70852

Ostrava

72076

Tübingen

75743

Paris

75908

Paris

75970

Paris

79106

Freiburg I. Br

81675

München

87042

Limoges

92151

Suresnes

93042

Regensburg

94010

Créteil

94275

Le Kremlin-Bicêtre

123182

Moscow

129090

Moscow

197110

Saint Petersburg

400006

Cluj-Napoca

404120

Volgograd

644112

Omsk

C1425FAB

Buenos Aires

X5016KEH

Córdoba

A-6020

Innsbruck

A-4010

Linz

A-1090

Vienna

06002

Nice

06120

Halle

07747

Jena

04103

Leipzig

Unknown

Dublin

00144

Roma

6202 AZ

Maastricht

NO-0027

Oslo

15-540

Bialystok

80-211

Gdansk

20-090

Lublin

60-479

Poznan

022-006

Warsaw

50-419

Wroclaw

1069-639

Lisbon

4099-001

Porto

022328

Bucharest

975 17

Banska Bysterica

040 11

Košice

02006

Albacete

03010

Alicante

08035

Barcelona

08907

Barcelona

07014

Palma de Mallorca

S-14186

Stockholm

S-75185

Uppsala

B15 2TH

Birmingham

G11 6NT

Glasgow

LE54PW

Leicester

M13 9WL

Manchester

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY

NCT00717470 - A Study in Kidney Transplant Subjects to Investigate the Optimal Suppression of Immunity to Help Prevent Kidney Rejection | Biotech Hunter | Biotech Hunter